KRYS R&D to Revenue

Krystal Biotech Inc · R&D to Revenue

KRYS logo

KRYS R&D to Revenue

Latest reported14.92%
KRYS FY R&D/Revenue (0.00% → 14.92%)
High-resolution chart · PNG

KRYS r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Krystal Biotech Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
14.9166%
18.4407%
91.5817%
0%
0%
0%
0%
755.6962%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.